Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

The double-edged power of the medications we prescribe

Hans Duvefelt, MD
Meds
July 30, 2018
Share
Tweet
Share

My patient, a rugged sixty year old with massively muscular forearms, gray chest hair at the V of his denim shirt, and a voice that suggested years of liquor and unfiltered cigarettes, lowered his voice and leaned forward.

“I’m not usually scared of anything, but for three nights now, ever since I started taking the Levaquin for this pneumonia, I have had the most horrific nightmares. I can’t even talk about them, that’s how terrifying they are. I have never been so scared in my life. You’ve got to get me on a different antibiotic, or I would rather let the pneumonia run its course.”

I had never heard of such a side effect from this commonly used broad-spectrum antibiotic, but a quick search on my iPhone yielded a long list of references to this phenomenon.

I agreed that he should stop his antibiotic, and prescribed a combination of two others that would be an appropriate treatment for him. I cautioned him to let us know if he started to feel worse on the new medications.

That night I did some research. It turns out levofloxacin and several other quinolone antibiotics can affect GABA receptors:

CNS effects of quinolones correlate with its binding to the receptors for γ-amino butyric acid (GABA) in the brain. GABA is an inhibitory neurotransmitter of brain. Quinolones prevent normal binding of GABA with their receptors. So it increases CNS stimulation. There are reports on quinolones directly activating N-methyl-d-aspartate (NMDA) and adenosine receptors. Thus, under specific conditions of sufficient CNS penetration, associated with antagonism of inhibitory pathways (GABA) and stimulation of excitatory pathways (NMDA, adenosine), observable CNS symptoms are manifested. This mechanism explains the pathogenesis of the acute anxiety and insomnia in the above cases with levofloxacin therapy. These mechanisms are even correlating with non-dopaminergic pathways of psychosis. It is even possible that the above-said cases might have progressed on to psychosis.

I thought back on another medication that I had seen cause bizarre and horrific psychological effects. The Swedish made antipsychotic quetiapine, or Seroquel, has caused frightening demonic visions and auditory hallucinations in a few patients I have encountered. While it seems unfortunate that an antipsychotic, often used off-label for benign things like insomnia, can cause psychiatric symptoms, it isn’t totally unimaginable that when we try to chemically manipulate the mind, things can go wrong. I wondered if others had noticed the same side effect and if there was a known mechanism behind it.

It didn’t take long before I found that Seroquel can cause an upregulation of dopamine receptors and that, if treatment isn’t stopped, irreversible psychosis can develop with long-term use:

Theoretical model illustrating the ability of chronic treatment with antipsychotic medication to induce dopamine supersensitivity. It is proposed that with chronic antipsychotic treatment (synapse on the right), there are increases in the numbers of dopamine D2 receptors (D2) and D2 receptors in a high-affinity state for dopamine (D2High) in the striatum, without significant changes in presynaptic dopamine release, synthesis, or reuptake. In turn, the D2 receptor upregulation enhances D2-mediated dopamine signaling, shown by the red arrows, thus producing a state of supersensitivity to dopamine agonist stimulation. The functional consequences of this dopamine supersensitivity would include antipsychotic treatment failure, supersensitivity-related psychosis, and movement disorders.

I was, as so often in my work, again humbled by the double-edged power of the medications we prescribe for our patients, and by the tremendous responsibility we have of choosing the right medicine for the right purpose. I was reminded of the difference in mentality I observed when I first moved from Sweden to this country: There, if the first treatment I chose didn’t work, it was nothing to be ashamed about. It simply justified using the “bigger guns.”

Here, if my first, and safest, treatment choice doesn’t work, it is a “treatment failure.” We are constantly tempted to prescribe the strongest medicine, which is often the most dangerous one.

“A Country Doctor” is a family physician who blogs at A Country Doctor Writes:.

Image credit: Shutterstock.com

ADVERTISEMENT

Prev

Is going to medical school a wise financial decision?

July 30, 2018 Kevin 8
…
Next

Is double health insurance coverage better?

July 30, 2018 Kevin 2
…

Tagged as: Infectious Disease

Post navigation

< Previous Post
Is going to medical school a wise financial decision?
Next Post >
Is double health insurance coverage better?

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

More by Hans Duvefelt, MD

  • The art of asking where it hurts

    Hans Duvefelt, MD
  • Thinking like a plumber when adjusting medications

    Hans Duvefelt, MD
  • The American food conspiracy

    Hans Duvefelt, MD

Related Posts

  • The ritual of taking medications: the pill wheel

    Fery Pashang, PharmD
  • When should you prescribe statins for older adults?

    Kenneth Lin, MD
  • Tips to help you afford medications

    Roy Benaroch, MD
  • Concerns about the generic formulations of ADHD medications

    Jolene Won
  • How can we improve the quality of medications?

    J. Leonard Lichtenfeld, MD
  • Seasoned medical professionals prescribe new medicines sparingly

    Michael Kirsch, MD

More in Meds

  • A world without antidepressants: What could possibly go wrong?

    Tomi Mitchell, MD
  • The truth about GLP-1 medications for weight loss: What every patient should know

    Nisha Kuruvadi, DO
  • The hidden bias in how we treat chronic pain

    Richard A. Lawhern, PhD
  • Biologics are not small molecules: the case for pre-allergy testing in an era of immune-based therapies

    Robert Trent
  • The anesthesia spectrum: Guiding patients through comfort options in oral surgery

    Dexter Mattox, MD, DMD
  • Functional precision oncology: a game changer in cancer therapy

    Chris Apfel, MD, PhD, MBA
  • Most Popular

  • Past Week

    • What’s driving medical students away from primary care?

      ​​Vineeth Amba, MPH, Archita Goyal, and Wayne Altman, MD | Education
    • A faster path to becoming a doctor is possible—here’s how

      Ankit Jain | Education
    • Why no medical malpractice firm responded to my scientific protocol

      Howard Smith, MD | Physician
    • A world without antidepressants: What could possibly go wrong?

      Tomi Mitchell, MD | Meds
    • Make cognitive testing as routine as a blood pressure check

      Joshua Baker and James Jackson, PsyD | Conditions
    • Bridging the digital divide: Addressing health inequities through home-based AI solutions

      Dr. Sreeram Mullankandy | Tech
  • Past 6 Months

    • What’s driving medical students away from primary care?

      ​​Vineeth Amba, MPH, Archita Goyal, and Wayne Altman, MD | Education
    • Internal Medicine 2025: inspiration at the annual meeting

      American College of Physicians | Physician
    • The silent crisis hurting pain patients and their doctors

      Kayvan Haddadan, MD | Physician
    • What happened to real care in health care?

      Christopher H. Foster, PhD, MPA | Policy
    • Are quotas a solution to physician shortages?

      Jacob Murphy | Education
    • How to build a culture where physicians feel valued [PODCAST]

      The Podcast by KevinMD | Podcast
  • Recent Posts

    • Make cognitive testing as routine as a blood pressure check

      Joshua Baker and James Jackson, PsyD | Conditions
    • Reimagining diabetes care with nutrition, not prescriptions

      William Hsu, MD | Conditions
    • Why funding cuts to academic medical centers impact all of us [PODCAST]

      The Podcast by KevinMD | Podcast
    • What’s driving medical students away from primary care?

      ​​Vineeth Amba, MPH, Archita Goyal, and Wayne Altman, MD | Education
    • When rock bottom is a turning point: Why the turmoil at HHS may be a blessing in disguise

      Muhamad Aly Rifai, MD | Physician
    • How grief transformed a psychiatrist’s approach to patient care

      Devina Maya Wadhwa, MD | Physician

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

Leave a Comment

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

  • Most Popular

  • Past Week

    • What’s driving medical students away from primary care?

      ​​Vineeth Amba, MPH, Archita Goyal, and Wayne Altman, MD | Education
    • A faster path to becoming a doctor is possible—here’s how

      Ankit Jain | Education
    • Why no medical malpractice firm responded to my scientific protocol

      Howard Smith, MD | Physician
    • A world without antidepressants: What could possibly go wrong?

      Tomi Mitchell, MD | Meds
    • Make cognitive testing as routine as a blood pressure check

      Joshua Baker and James Jackson, PsyD | Conditions
    • Bridging the digital divide: Addressing health inequities through home-based AI solutions

      Dr. Sreeram Mullankandy | Tech
  • Past 6 Months

    • What’s driving medical students away from primary care?

      ​​Vineeth Amba, MPH, Archita Goyal, and Wayne Altman, MD | Education
    • Internal Medicine 2025: inspiration at the annual meeting

      American College of Physicians | Physician
    • The silent crisis hurting pain patients and their doctors

      Kayvan Haddadan, MD | Physician
    • What happened to real care in health care?

      Christopher H. Foster, PhD, MPA | Policy
    • Are quotas a solution to physician shortages?

      Jacob Murphy | Education
    • How to build a culture where physicians feel valued [PODCAST]

      The Podcast by KevinMD | Podcast
  • Recent Posts

    • Make cognitive testing as routine as a blood pressure check

      Joshua Baker and James Jackson, PsyD | Conditions
    • Reimagining diabetes care with nutrition, not prescriptions

      William Hsu, MD | Conditions
    • Why funding cuts to academic medical centers impact all of us [PODCAST]

      The Podcast by KevinMD | Podcast
    • What’s driving medical students away from primary care?

      ​​Vineeth Amba, MPH, Archita Goyal, and Wayne Altman, MD | Education
    • When rock bottom is a turning point: Why the turmoil at HHS may be a blessing in disguise

      Muhamad Aly Rifai, MD | Physician
    • How grief transformed a psychiatrist’s approach to patient care

      Devina Maya Wadhwa, MD | Physician

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Leave a Comment

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...